Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Interest Expenses (2018 - 2025)

Puma Biotechnology (PBYI) has disclosed Interest Expenses for 8 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses fell 57.31% year-over-year to $1.1 million, compared with a TTM value of $6.6 million through Dec 2025, down 46.82%, and an annual FY2025 reading of $6.6 million, down 46.82% over the prior year.
  • Interest Expenses was $1.1 million for Q4 2025 at Puma Biotechnology, down from $1.5 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $3.5 million in Q2 2021 and bottomed at $1.1 million in Q4 2025.
  • Average Interest Expenses over 5 years is $2.8 million, with a median of $3.1 million recorded in 2021.
  • The sharpest move saw Interest Expenses increased 24.32% in 2023, then tumbled 57.31% in 2025.
  • Year by year, Interest Expenses stood at $2.7 million in 2021, then increased by 20.64% to $3.3 million in 2022, then increased by 2.29% to $3.4 million in 2023, then dropped by 21.85% to $2.6 million in 2024, then crashed by 57.31% to $1.1 million in 2025.
  • Business Quant data shows Interest Expenses for PBYI at $1.1 million in Q4 2025, $1.5 million in Q3 2025, and $1.8 million in Q2 2025.